Changes in non-hypervascular hypointense nodules during hepatobiliary phase of Gd-EOB-DTPA enhanced MRI in patients with chronic hepatitis C after the eradication of HCV

Changes in non-hypervascular hypointense nodules during hepatobiliary phase of Gd-EOB-DTPA enhanced MRI in patients with chronic hepatitis C after the eradication of HCV - Changes in non-hypervascular hypointense nodules during hepatobiliary phase of Gd-EOB-DTPA enhanced MRI in patients with chronic hepatitis C after the eradication of HCV

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000017020

Enrollment

500

Registered

2015-04-15

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with chronic HCV infection who are planning to undergo antiviral therapy for HCV

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with chronic HCV infection who are planning to undergo antiviral therapy for HCV.

Exclusion criteria

Exclusion criteria: Patients who have a history of hepatocellular carcinoma.

Design outcomes

Primary

Measure	Time frame
Serial changes of non-hypervascular hypointense nodules during hepatobiliary phase of Gd-EOB-DTPA enhanced MRI after the eradication of HCV in patients with chronic hepatitis C.	—

Secondary

Measure	Time frame
The incidence of the evolution of non-hypervascular hypointense nodules during hepatobiliary phase of Gd-EOB-DTPA enhanced MRI to hyper vascular tumors including hepatocellular carcinoma.	—

Countries

Japan

Contacts

Public ContactHidenori Toyoda

Ogaki Municipal Hospital Gastroenterology

tkumada@he.mirai.ne.jp0584-81-3341(1563)

Outcome results